Form 8-K - Current report:
SEC Accession No. 0001842952-23-000065
Filing Date
2023-06-02
Accepted
2023-06-02 16:05:06
Documents
12
Period of Report
2023-05-31
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K cntx-20230531.htm   iXBRL 8-K 39352
  Complete submission text file 0001842952-23-000065.txt   188179

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cntx-20230531.xsd EX-101.SCH 1935
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cntx-20230531_lab.xml EX-101.LAB 26869
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cntx-20230531_pre.xml EX-101.PRE 14141
6 EXTRACTED XBRL INSTANCE DOCUMENT cntx-20230531_htm.xml XML 11842
Mailing Address 2001 MARKET STREET SUITE 3915 UNIT #15 PHILADELPHIA PA 19103
Business Address 2001 MARKET STREET SUITE 3915 UNIT #15 PHILADELPHIA PA 19103 267-225-7416
Context Therapeutics Inc. (Filer) CIK: 0001842952 (see all company filings)

EIN.: 863738787 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40654 | Film No.: 23988624
SIC: 2834 Pharmaceutical Preparations